Cancer Clinical Trial Proposal Could Open Door to Thousands (1)

New cancer therapies could reach patients more quickly under a proposal by two cancer groups to increase access to the clinical trials that are essential for FDA approval.

The proposal, which the groups sent Aug. 9 to the Food and Drug Administration, would allow patient populations that typically have been excluded from participating in cancer clinical trials, including adolescents, HIV patients, and those whose cancers have spread, or metastasized, to the brain. The brain metastases proposal alone would open up cancer trials to the patients with the 70,000 diagnoses of brain metastases that occur each year in the U.S.

Clinical ...